ABT-510 - Thrombospondin-1 mimetic

DRUG2 trials

Sponsors

Abbott

Conditions

Hodgkin's LymphomaLymphoma, Non-HodgkinSarcoma, Soft Tissue

Phase 2

Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma

CompletedNCT00061659

AbbottSarcoma, Soft Tissue

Start: 2003-05-31End: 2006-04-30Updated: 2007-11-29

Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma

CompletedNCT00061672

AbbottHodgkin's Lymphoma, Lymphoma, Non-Hodgkin

Start: 2003-04-30Updated: 2007-08-15